Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Precancerous Conditions 1Oropharyngeal Neoplasms 1Mouth Neoplasms 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1Cardiotoxicity 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

Cisplatin 12Radiotherapy 10Cetuximab 9Fluorouracil 6Drug Therapy 5Docetaxel 5pembrolizumab 3Radiotherapy, Intensity-Modulated 3Radiation 3Laser Therapy 3Hydroxyurea 3sargramostim 2Surveys and Questionnaires 2Resistance Training 2Psychiatric Rehabilitation 2Nutritional Status 2Nicotine 2Counseling 2Celecoxib 2Carboplatin 2Bupropion 2Bronchoscopy 2sodium thiosulfate 1motexafin gadolinium 1gossypol acetic acid 1durvalumab 1adavosertib 1Zinc Oxide 1Varenicline 1Transcutaneous Electric Nerve Stimulation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Laryngeal Neoplasms × Fluorophotometry × Clear all
NCT00002964 2013-02-05

Porfimer Sodium in Diagnosing Patients With Head and Neck Cancer

Roswell Park Cancer Institute

Phase 2 Completed
Head & Neck

Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡